Scienture Holdings, Inc.
SCNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001382574
No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Scienture Holdings, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- 0 vs. Q2 2022
- Shares held
- 579.3K
- −7.54K (−1.3%) vs. Q2 2022
- Total value
- $658.0K
- −$295.0K (−31.0%) vs. Q2 2022
- New holders
- 1
- 3 more added
- Sold out
- 1
- 1 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $709.1K |
| Q1 2026 | 13 | $405.1K |
| Q4 2025 | 12 | $693.6K |
| Q3 2025 | 11 | $381.8K |
| Q2 2025 | 8 | $111.9K |
| Q1 2025 | 9 | $160.1K |
| Q4 2024 | 9 | $566.7K |
| Q3 2024 | 7 | $301.5K |
| Q2 2024 | 6 | $395.7K |
| Q1 2024 | 9 | $805.3K |
| Q4 2023 | 6 | $14.5K |
| Q3 2023 | 6 | $14.2K |
| Q2 2023 | 8 | $298.2K |
| Q1 2023 | 12 | $69.2K |
| Q4 2022 | 15 | $376.0K |
| Q3 2022 | 13 | $658.0K |
| Q2 2022 | 13 | $953.0K |
| Q1 2022 | 13 | $1.49M |
| Q4 2021 | 15 | $1.52M |
| Q3 2021 | 11 | $2.60M |
| Q2 2021 | 12 | $2.25M |
| Q1 2021 | 15 | $5.83M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Scienture Holdings, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ridgewood Investments LLC | 200,600 | $227.0K | 0.19% | 00.0% | Unchanged |
| Vanguard Group Inc | 179,271 | $203.0K | 0.00% | +8,726+5.1% | Added |
| National Asset Management, Inc. | 85,136 | $97.0K | 0.00% | −28,467−25.1% | Reduced |
| Geode Capital Management, LLC | 42,057 | $47.0K | 0.00% | 00.0% | Unchanged |
| Wealth Dimensions Group, Ltd. | 30,979 | $35.0K | 0.02% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 14,969 | $17.0K | 0.00% | +14,969 | New |
| Tower Research Capital LLC (TRC) | 9,052 | $10.0K | 0.00% | +6,964+333.5% | Added |
| Ronald Blue Trust, Inc. | 5,354 | $9.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,551 | $5.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,840 | $4.00K | 0.00% | +3,465+924.0% | Added |
| Spire Wealth Management | 2,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 22 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −13,195−100.0% | Sold out |